Cancer Biological Therapy Market By Product Type and Distribution Channel - Global Industry Analysis & Forecast to 2025

Published On : January 2019 Pages : 130 Category: Pharma & Healthcare Report Code : HC012276

Cancer Biological Therapy Market By Product Type (Cancer growth blockers, Cytokines, Gene therapy, Vaccines, Monoclonal antibodies, Blood cell growth factors) Distribution Channel (Retail pharmacies, Hospital pharmacies, Mail order pharmacies) - Global Industry Analysis & Forecast to 2025

Industry Outlook and Trend Analysis

The Cancer Biological Therapy Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Biological cancer treatments make use of the immune system of the body, either indirectly or in a directly way, to battle disease or to diminish the symptoms that might be caused by some cancer therapies. It is additionally known as biotherapy or biological reaction modifiers. Interferons and monoclonal antibodies are among the most encouraging natural ways to deal with cancer treatment. Biological treatment works by boosting, stimulating, reestablishing or acting like the body's immune system response against the cells that are cancerous.

Drivers and Restraints

Major factors, for example, developing pervasiveness of cancer, constant patent expiry of cancer medications, rising effect of biosimilars and expanding request of natural and focused on medication treatments will drive the general cancer biological therapy market. As per WHO, the quantity of new malignant growth cases is anticipated to rise 70% in the coming two decades, predominantly because of expanded utilization of tobacco and liquor utilization. Nonetheless, the risk of failure in therapy, the staggering expense of medication advancement, the unfriendly impacts of cancer drug treatment, especially chemotherapy and stricter government directions will ruins the general cancer biological therapy market growth globally.

Regional Insights

Geographically, North America overwhelms a noteworthy offer of the worldwide Cancer Biological Therapy market. The North American market is trailed by Europe, Asia Pacific.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche AG
  • Merck & Co., Inc
  • Eli Lilly
  • Seattle Genetics, Inc
  • Amgen Inc
  • Celgene Corporation
  • Novartis International AG
  • GlaxoSmithKline Plc
  • Spectrum Pharmaceuticals, Inc

Some of the key questions answered by the report are:

  • What was the market size in 2014 and forecast from 2015 to 2025?
  • What will be the industry market growth from 2015 to 2025?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Cancer Biological Therapy Market, By Product Type, Estimates and Forecast, 2014-2025 ($Million)

·         Cancer growth blockers

·         Cytokines

·         Gene therapy

·         Vaccines

·         Monoclonal antibodies

·         Blood cell growth factors

·         Cancer Biological Therapy Market, By Distribution Channel, Estimates and Forecast, 2014-2025 ($Million)

·         Retail pharmacies

·         Hospital pharmacies

·         Mail order pharmacies

·         Cancer Biological Therapy Market, By Region, Estimates and Forecast, 2014-2025 ($Million)

·         North America

§  North America Cancer Biological Therapy Market, By Country

o    U.S. Cancer Biological Therapy Market

o    Canada Cancer Biological Therapy Market

o    Mexico Cancer Biological Therapy Market

·         Europe

§  Europe Cancer Biological Therapy Market, By Country

o    Germany Cancer Biological Therapy Market

o    UK Cancer Biological Therapy Market

o    France Cancer Biological Therapy Market

o    Russia Cancer Biological Therapy Market

o    Italy Cancer Biological Therapy Market

o    Rest of Europe Cancer Biological Therapy Market

·         Asia-Pacific

§  Asia-Pacific Cancer Biological Therapy Market, By Country

o    China Cancer Biological Therapy Market

o    Japan Cancer Biological Therapy Market

o    South Korea Cancer Biological Therapy Market

o    India Cancer Biological Therapy Market

o    Southeast Asia Cancer Biological Therapy Market

o    Rest of Asia-Pacific Cancer Biological Therapy Market

·         South America

§  South America Cancer Biological Therapy Market

o    Brazil Cancer Biological Therapy Market

o    Argentina Cancer Biological Therapy Market

o    Columbia Cancer Biological Therapy Market

o    Rest of South America Cancer Biological Therapy Market

·         Middle East and Africa

§  Middle East and Africa Cancer Biological Therapy Market

o    Saudi Arabia Cancer Biological Therapy Market

o    UAE Cancer Biological Therapy Market

o    Egypt Cancer Biological Therapy Market

o    Nigeria Cancer Biological Therapy Market

o    South Africa Cancer Biological Therapy Market

o    Rest of MEA Cancer Biological Therapy Market

Table of Contents

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.3.     SWOT Analysis

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2014-2025)

4.1.2.  Canada Market Status and Outlook (2014-2025)

4.1.3.  Mexico Market Status and Outlook (2014-2025)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2014-2025)

4.2.2.  France Market Status and Outlook (2014-2025)

4.2.3.  UK Market Status and Outlook (2014-2025)

4.2.4.  Russia Market Status and Outlook (2014-2025)

4.2.5.  Italy Market Status and Outlook (2014-2025)

4.2.6.  Rest of Europe Market Status and Outlook (2014-2025)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2014-2025)

4.3.2.  Japan Market Status and Outlook (2014-2025)

4.3.3.  Korea Market Status and Outlook (2014-2025)

4.3.4.  India Market Status and Outlook (2014-2025)

4.3.5.  Southeast Asia Market Status and Outlook (2014-2025)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2014-2025)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2014-2025)

4.4.2.  Argentina Market Status and Outlook (2014-2025)

4.4.3.  Columbia Market Status and Outlook (2014-2025)

4.4.4.  Rest of South America Market Status and Outlook (2014-2025)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2014-2025)

4.5.2.  United Arab Emirates Market Status and Outlook (2014-2025)

4.5.3.  Egypt Market Status and Outlook (2014-2025)

4.5.4.  Nigeria Market Status and Outlook (2014-2025)

4.5.5.  South Africa Market Status and Outlook (2014-2025)

4.5.6.  Turkey Market Status and Outlook (2014-2025)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2014-2025)

5.       Cancer Biological Therapy Market, By Product Type

5.1.     Introduction

5.2.     Global Cancer Biological Therapy Revenue and Market Share by Product Type (2014-2018)

5.2.1.  Global Cancer Biological Therapy Revenue and Revenue Share by Product Type (2014-2018)

5.3.     Cancer growth blockers

5.3.1.  Global Cancer growth blockers Revenue and Growth Rate (2014-2018)

5.4.     Cytokines

5.4.1.  Global Cytokines Revenue and Growth Rate (2014-2018)

5.5.     Gene therapy

5.5.1.  Global Gene therapy Revenue and Growth Rate (2014-2018)

5.6.     Vaccines

5.6.1.  Global Vaccines Revenue and Growth Rate (2014-2018)

5.7.     Monoclonal antibodies

5.7.1.  Global Monoclonal antibodies Revenue and Growth Rate (2014-2018)

5.8.     Blood cell growth factors

5.8.1.  Global Blood cell growth factors Revenue and Growth Rate (2014-2018)

6.       Cancer Biological Therapy Market, By Distribution Channel

6.1.     Introduction

6.2.     Global Cancer Biological Therapy Revenue and Market Share by Distribution Channel (2014-2018)

6.2.1.  Global Cancer Biological Therapy Revenue and Revenue Share by Distribution Channel (2014-2018)

6.3.     Retail pharmacies

6.3.1.  Global Retail pharmacies Revenue and Growth Rate (2014-2018)

6.4.     Hospital pharmacies

6.4.1.  Global Hospital pharmacies Revenue and Growth Rate (2014-2018)

6.5.     Mail order pharmacies

6.5.1.  Global Mail order pharmacies Revenue and Growth Rate (2014-2018)

7.       Cancer Biological Therapy Market, By Region

7.1.     Introduction

7.2.     Global Cancer Biological Therapy Revenue and Market Share by Regions

7.2.1.  Global Cancer Biological Therapy Revenue by Regions (2014-2018)

7.3.     North America Cancer Biological Therapy by Countries

7.3.1.  North America Cancer Biological Therapy Revenue and Growth Rate (2014-2018)

7.3.2.  North America Cancer Biological Therapy Revenue (Million USD) by Countries (2014-2018)

7.3.3.  United States

7.3.3.1.  United States Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

7.3.4.  Canada

7.3.4.1.  Canada Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

7.3.5.  Mexico

7.3.5.1.  Mexico Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.     Europe Cancer Biological Therapy by Countries

7.4.1.  Europe Cancer Biological Therapy Revenue and Growth Rate (2014-2018)

7.4.2.  Europe Cancer Biological Therapy Revenue (Million USD) by Countries (2014-2018)

7.4.3.  Germany

7.4.3.1.  Germany Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.4.  France

7.4.4.1.  France Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.5.  UK

7.4.5.1.  UK Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.6.  Russia

7.4.6.1.  Russia Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.7.  Italy

7.4.7.1.  Italy Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.     Asia-Pacific Cancer Biological Therapy by Countries

7.5.1.  Asia-Pacific Cancer Biological Therapy Revenue and Growth Rate (2014-2018)

7.5.2.  Asia-Pacific Cancer Biological Therapy Revenue (Million USD) by Countries (2014-2018)

7.5.3.  China

7.5.3.1.  China Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.4.  Japan

7.5.4.1.  Japan Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.5.  Korea

7.5.5.1.  Korea Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.6.  India

7.5.6.1.  India Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.     South America Cancer Biological Therapy by Countries

7.6.1.  South America Cancer Biological Therapy Revenue and Growth Rate (2014-2018)

7.6.2.  South America Cancer Biological Therapy Revenue (Million USD) by Countries (2014-2018)

7.6.3.  Brazil

7.6.3.1.  Brazil Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.4.  Argentina

7.6.4.1.  Argentina Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.5.  Columbia

7.6.5.1.  Columbia Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.     Middle East and Africa Cancer Biological Therapy by Countries

7.7.1.  Middle East and Africa Cancer Biological Therapy Revenue and Growth Rate (2014-2018)

7.7.2.  Middle East and Africa Cancer Biological Therapy Revenue (Million USD) by Countries (2014-2018)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.5.  Egypt

7.7.5.1.  Egypt Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.7.  South Africa

7.7.7.1.  South Africa Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.8.  Turkey

7.7.8.1.  Turkey Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

8.       Company Profiles

8.1.     Bristol-Myers Squibb

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.   Revenue and Market Share

8.2.     F. Hoffmann-La Roche AG

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.   Revenue and Market Share

8.3.     Merck & Co Inc

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.   Revenue and Market Share

8.4.     Eli Lilly

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.   Revenue and Market Share

8.5.     Seattle Genetics, Inc

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.   Revenue and Market Share

8.6.     Amgen Inc

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.   Revenue and Market Share

8.7.     Celgene Corporation

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.   Revenue and Market Share

8.8.     Novartis International AG

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.   Revenue and Market Share

8.9.     GlaxoSmithKline Plc

8.9.1.  Business Overview

8.9.2.   Service Portfolio

8.9.3.  Strategic Developments

8.9.4.   Revenue and Market Share

8.10. Spectrum Pharmaceuticals, Inc

8.10.1.      Business Overview

8.10.2.       Service Portfolio

8.10.3.      Strategic Developments

8.10.4.       Revenue and Market Share

9.       Global Cancer Biological Therapy Market Competition, by Manufacturer

9.1.     Global Cancer Biological Therapy Revenue and Market Share by Manufacturer (2016-2017)

9.2.     Global Cancer Biological Therapy Price By Region (2016-2017)

9.3.     Top 5 Cancer Biological Therapy Manufacturer Market Share

9.4.     Market Competition Trend

10.    Cancer Biological Therapy Market Forecast (2018-2025)

10.1. Global Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2018-2025)

10.2. Cancer Biological Therapy Market Forecast by Regions (2018-2025)

10.2.1.      North America Cancer Biological Therapy Market Forecast (2018-2025)

10.2.1.1. United States Cancer Biological Therapy Market Forecast (2018-2025)

10.2.1.2. Canada Cancer Biological Therapy Market Forecast (2018-2025)

10.2.1.3. Mexico Cancer Biological Therapy Market Forecast (2018-2025)

10.2.2.      Europe Cancer Biological Therapy Market Forecast (2018-2025)

10.2.2.1. Germany Cancer Biological Therapy Market Forecast (2018-2025)

10.2.2.2. France Cancer Biological Therapy Market Forecast (2018-2025)

10.2.2.3. UK Cancer Biological Therapy Market Forecast (2018-2025)

10.2.2.4. Russia Cancer Biological Therapy Market Forecast (2018-2025)

10.2.2.5. Italy Cancer Biological Therapy Market Forecast (2018-2025)

10.2.2.6. Rest of Europe Cancer Biological Therapy Market Forecast (2018-2025)

10.2.3.      Asia-Pacific Cancer Biological Therapy Market Forecast (2018-2025)

10.2.3.1. China Cancer Biological Therapy Market Forecast (2018-2025)

10.2.3.2. Japan Cancer Biological Therapy Market Forecast (2018-2025)

10.2.3.3. Korea Cancer Biological Therapy Market Forecast (2018-2025)

10.2.3.4. India Cancer Biological Therapy Market Forecast (2018-2025)

10.2.3.5. Southeast Asia Cancer Biological Therapy Market Forecast (2018-2025)

10.2.3.6. Rest of Asia-Pacific Cancer Biological Therapy Market Forecast (2018-2025)

10.2.4.      South America Cancer Biological Therapy Market Forecast (2018-2025)

10.2.4.1. Brazil Cancer Biological Therapy Market Forecast (2018-2025)

10.2.4.2. Argentina Cancer Biological Therapy Market Forecast (2018-2025)

10.2.4.3. Columbia Cancer Biological Therapy Market Forecast (2018-2025)

10.2.4.4. Rest of South America Cancer Biological Therapy Market Forecast (2018-2025)

10.2.5.      Middle East and Africa Cancer Biological Therapy Market Forecast (2018-2025)

10.2.5.1. Saudi Arabia Cancer Biological Therapy Market Forecast (2018-2025)

10.2.5.2. United Arab Emirates Cancer Biological Therapy Market Forecast (2018-2025)

10.2.5.3. Egypt Cancer Biological Therapy Market Forecast (2018-2025)

10.2.5.4. Nigeria Cancer Biological Therapy Market Forecast (2018-2025)

10.2.5.5. South Africa Cancer Biological Therapy Market Forecast (2018-2025)

10.2.5.6. Turkey Cancer Biological Therapy Market Forecast (2018-2025)

10.2.5.7. Rest of Middle East and Africa Cancer Biological Therapy Market Forecast (2018-2025)

10.3. Cancer Biological Therapy Market Forecast by Product Type (2018-2025)

10.3.1.      Cancer Biological Therapy Forecast by Product Type (2018-2025)

10.3.2.      Cancer Biological Therapy Market Share Forecast by Product Type (2018-2025)

10.4. Cancer Biological Therapy Market Forecast by Distribution Channel (2018-2025)

10.4.1.      Cancer Biological Therapy Forecast by Distribution Channel (2018-2025)

10.4.2.      Cancer Biological Therapy Market Share Forecast by Distribution Channel (2018-2025)


List of Tables

List of Tables and Figures:

Figure United States Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Canada Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Mexico Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Germany Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure France Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure UK Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Russia Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Italy Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Europe Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Korea Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure India Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Southeast Asia Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Asia-Pacific Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Brazil Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Argentina Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Columbia Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of South America Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Saudi Arabia Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure United Arab Emirates Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Egypt Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Nigeria Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure South Africa Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Turkey Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Middle East and Africa Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Table Global Cancer Biological Therapy Revenue and Revenue Share by Product Type (2014-2018)
Figure Global Cancer growth blockers Revenue and Growth Rate (2014-2018)
Figure Global Cytokines Revenue and Growth Rate (2014-2018)
Figure Global Gene therapy Revenue and Growth Rate (2014-2018)
Figure Global Vaccines Revenue and Growth Rate (2014-2018)
Figure Global Monoclonal antibodies Revenue and Growth Rate (2014-2018)
Figure Global Blood cell growth factors Revenue and Growth Rate (2014-2018)
Table Global Cancer Biological Therapy Revenue and Revenue Share by Distribution Channel (2014-2018)
Figure Global Retail pharmacies Revenue and Growth Rate (2014-2018)
Figure Global Hospital pharmacies Revenue and Growth Rate (2014-2018)
Figure Global Mail order pharmacies Revenue and Growth Rate (2014-2018)
Table Global Cancer Biological Therapy Revenue by Regions (2014-2018)
Figure North America Cancer Biological Therapy Growth Rate (2014-2018)
Figure North America Cancer Biological Therapy Revenue and Growth Rate (2014-2018)
Figure North America Cancer Biological Therapy by Countries (2014-2018)
Figure North America Cancer Biological Therapy Revenue (Million USD) by Countries (2014-2018)
Figure United States Cancer Biological Therapy Growth Rate (2014-2018)
Figure United States Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Canada Cancer Biological Therapy Growth Rate (2014-2018)
Figure Canada Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Mexico Cancer Biological Therapy Growth Rate (2014-2018)
Figure Mexico Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Europe Cancer Biological Therapy Growth Rate (2014-2018)
Figure Europe Cancer Biological Therapy Revenue and Growth Rate (2014-2018)
Figure Europe Cancer Biological Therapy by Countries (2014-2018)
Figure Europe Cancer Biological Therapy Revenue (Million USD) by Countries (2014-2018)
Figure Germany Cancer Biological Therapy Growth Rate (2014-2018)
Figure Germany Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure France Cancer Biological Therapy Growth Rate (2014-2018)
Figure France Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure UK Cancer Biological Therapy Growth Rate (2014-2018)
Figure UK Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Russia Cancer Biological Therapy Growth Rate (2014-2018)
Figure Russia Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Italy Cancer Biological Therapy Growth Rate (2014-2018)
Figure Italy Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Europe Cancer Biological Therapy Growth Rate (2014-2018)
Figure Rest of Europe Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Asia-Pacific Cancer Biological Therapy Growth Rate (2014-2018)
Figure Asia-Pacific Cancer Biological Therapy Revenue and Growth Rate (2014-2018)
Figure Asia-Pacific Cancer Biological Therapy by Countries (2014-2018)
Figure Asia-Pacific Cancer Biological Therapy Revenue (Million USD) by Countries (2014-2018)
Figure China Cancer Biological Therapy Growth Rate (2014-2018)
Figure China Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Japan Cancer Biological Therapy Growth Rate (2014-2018)
Figure Japan Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Korea Cancer Biological Therapy Growth Rate (2014-2018)
Figure Korea Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure India Cancer Biological Therapy Growth Rate (2014-2018)
Figure India Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Southeast Asia Cancer Biological Therapy Growth Rate (2014-2018)
Figure Southeast Asia Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Asia-Pacific Cancer Biological Therapy Growth Rate (2014-2018)
Figure Rest of Asia-Pacific Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South America Cancer Biological Therapy Growth Rate (2014-2018)
Figure South America Cancer Biological Therapy Revenue and Growth Rate (2014-2018)
Figure South America Cancer Biological Therapy by Countries (2014-2018)
Figure South America Cancer Biological Therapy Revenue (Million USD) by Countries (2014-2018)
Figure Brazil Cancer Biological Therapy Growth Rate (2014-2018)
Figure Brazil Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Argentina Cancer Biological Therapy Growth Rate (2014-2018)
Figure Argentina Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Columbia Cancer Biological Therapy Growth Rate (2014-2018)
Figure Columbia Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of South America Cancer Biological Therapy Growth Rate (2014-2018)
Figure Rest of South America Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Middle East and Africa Cancer Biological Therapy Growth Rate (2014-2018)
Figure Middle East and Africa Cancer Biological Therapy Revenue and Growth Rate (2014-2018)
Figure Middle East and Africa Cancer Biological Therapy by Countries (2014-2018)
Figure Middle East and Africa Cancer Biological Therapy Revenue (Million USD) by Countries (2014-2018)
Figure Saudi Arabia Cancer Biological Therapy Growth Rate (2014-2018)
Figure Saudi Arabia Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure United Arab Emirates Cancer Biological Therapy Growth Rate (2014-2018)
Figure United Arab Emirates Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Egypt Cancer Biological Therapy Growth Rate (2014-2018)
Figure Egypt Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Nigeria Cancer Biological Therapy Growth Rate (2014-2018)
Figure Nigeria Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South Africa Cancer Biological Therapy Growth Rate (2014-2018)
Figure South Africa Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Turkey Cancer Biological Therapy Growth Rate (2014-2018)
Figure Turkey Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Middle East and Africa Cancer Biological Therapy Growth Rate (2014-2018)
Figure Rest of Middle East and Africa Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Table Bristol-Myers Squibb Cancer Biological Therapy Price, Revenue, Gross Margin and Market Share (2016-2017)
Table F. Hoffmann-La Roche AG Cancer Biological Therapy Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck & Co Inc Cancer Biological Therapy Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Cancer Biological Therapy Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Seattle Genetics, Inc Cancer Biological Therapy Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Inc Cancer Biological Therapy Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Celgene Corporation Cancer Biological Therapy Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis International AG Cancer Biological Therapy Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Plc Cancer Biological Therapy Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Spectrum Pharmaceuticals, Inc Cancer Biological Therapy Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Cancer Biological Therapy Market Share by Manufacturer
Figure Global Cancer Biological Therapy Revenue and Market Share by Manufacturer
Table Global Cancer Biological Therapy Price by Region (2016-2017)
Figure Top 5 Cancer Biological Therapy Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2018-2025)
Table Cancer Biological Therapy Market Forecast by Regions (2018-2025)
Figure North America Cancer Biological Therapy Market Forecast (2018-2025)
Figure United States Cancer Biological Therapy Market Forecast (2018-2025)
Figure Canada Cancer Biological Therapy Market Forecast (2018-2025)
Figure Mexico Cancer Biological Therapy Market Forecast (2018-2025)
Figure Europe Cancer Biological Therapy Market Forecast (2018-2025)
Figure Germany Cancer Biological Therapy Market Forecast (2018-2025)
Figure France Cancer Biological Therapy Market Forecast (2018-2025)
Figure UK Cancer Biological Therapy Market Forecast (2018-2025)
Figure Russia Cancer Biological Therapy Market Forecast (2018-2025)
Figure Italy Cancer Biological Therapy Market Forecast (2018-2025)
Figure Rest of Europe Cancer Biological Therapy Market Forecast (2018-2025)
Figure Asia-Pacific Cancer Biological Therapy Market Forecast (2018-2025)
Figure China Cancer Biological Therapy Market Forecast (2018-2025)
Figure Japan Cancer Biological Therapy Market Forecast (2018-2025)
Figure Korea Cancer Biological Therapy Market Forecast (2018-2025)
Figure India Cancer Biological Therapy Market Forecast (2018-2025)
Figure Southeast Asia Cancer Biological Therapy Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Cancer Biological Therapy Market Forecast (2018-2025)
Figure South America Cancer Biological Therapy Market Forecast (2018-2025)
Figure Brazil Cancer Biological Therapy Market Forecast (2018-2025)
Figure Argentina Cancer Biological Therapy Market Forecast (2018-2025)
Figure Columbia Cancer Biological Therapy Market Forecast (2018-2025)
Figure Rest of South America Cancer Biological Therapy Market Forecast (2018-2025)
Figure Middle East and Africa Cancer Biological Therapy Market Forecast (2018-2025)
Figure Saudi Arabia Cancer Biological Therapy Market Forecast (2018-2025)
Figure United Arab Emirates Cancer Biological Therapy Market Forecast (2018-2025)
Figure Egypt Cancer Biological Therapy Market Forecast (2018-2025)
Figure Nigeria Cancer Biological Therapy Market Forecast (2018-2025)
Figure South Africa Cancer Biological Therapy Market Forecast (2018-2025)
Figure Turkey Cancer Biological Therapy Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Cancer Biological Therapy Market Forecast (2018-2025)
Figure Global Cancer Biological Therapy Forecast by Product Type (2018-2025)
Figure Global Cancer Biological Therapy Market Share Forecast by Product Type (2018-2025)
Figure Global Cancer Biological Therapy Forecast by Product Type (2018-2025)
Figure Global Cancer Biological Therapy Forecast by Distribution Channel (2018-2025)
Figure Global Cancer Biological Therapy Market Share Forecast by Distribution Channel (2018-2025)
Figure Global Cancer Biological Therapy Forecast by Distribution Channel (2018-2025)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*